吸入茶叶多荷载的纳米颗粒被血小板膜覆盖,在很大程度上减轻了喘性炎症
Suidong Ouyang1, Peishan Lu2, Jianing Li2
1Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, College of Medical Technology, Guangdong Medical University, Dongguan, 523808, China. ouyangsd@gdmu.edu.cn.
Respiratory research
|August 17, 2024
概括
携带茶叶聚醇 (PM@TP/NP) 的血小板膜涂层纳米颗粒在喘模型中有效降低肺炎. 这种新的纳米平台增强了茶叶多的输送,为喘治疗提供了一个有前途的治疗策略.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 茶叶多 (TPs) 具有抗氧化和抗炎性质,但其生物可用性较差.
- 一个仿生纳米平台 (PM@TP/NPs) 已经开发使用血小板膜 (PM) 涂在聚乳酸-co-甘油酸 (PLGA) 纳米颗粒 (NP) 上,以改善TP传递.
- 这个平台针对炎症组织,解决喘治疗的局限性.
研究的目的:
- 开发和描述PM@TP/NP,以提高TP的交付效率.
- 在喘模型中评估PM@TP/NP的生物相容性,生物安全性和治疗疗效.
- 阐明PM@TP/NP在缓解喘相关炎症方面的潜在机制.
主要方法:
- 合成并描述了PM@TP/NP的特征.
- 通过细胞活力,血液溶解和体内/体内炎症试验评估生物相容性和生物安全性.
- 在室内灰尘虫 (HDM) 诱导的小鼠喘模型中评估治疗效果,分析ROS清理和关键信号通路 (Nrf2/HO-1,CCL2/MAPK,TLR4/NF-κB).
主要成果:
- 与免费的TP相比,PM@TP/NP表现出卓越的生物相容性和安全性,肺部保留能力提高.
- 吸入的PM@TP/NP显著降低了喘小鼠的肺炎和2型前炎性细胞因子分泌.
- 治疗效应与增强的ROS清除,Nrf2/HO-1通路激活以及抑制的CCL2/MAPK和TLR4/NF-κB通路有关.
结论:
- 在小鼠模型中,吸入PM@TP/NP有效地减轻了室内灰尘引发的喘.
- PM@TP/NP代表了喘管理的新且有前途的治疗策略.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
255
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
255
01:20Asthma: Pathogenesis and Management
376
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
376
01:17Drugs Used in Lower Respiratory Disorders: Overview
370
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
370
01:24Antiasthma Drugs: Methylxanthines
211
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
211
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
145
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
145
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
230
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
230